BR112022003985A2 - Ácidos graxos poliinsaturados de cadeia muito longa, derivados elovanoides hidroxilados e métodos de uso - Google Patents

Ácidos graxos poliinsaturados de cadeia muito longa, derivados elovanoides hidroxilados e métodos de uso

Info

Publication number
BR112022003985A2
BR112022003985A2 BR112022003985A BR112022003985A BR112022003985A2 BR 112022003985 A2 BR112022003985 A2 BR 112022003985A2 BR 112022003985 A BR112022003985 A BR 112022003985A BR 112022003985 A BR112022003985 A BR 112022003985A BR 112022003985 A2 BR112022003985 A2 BR 112022003985A2
Authority
BR
Brazil
Prior art keywords
methods
hydroxylated
derivatives
fatty acids
long chain
Prior art date
Application number
BR112022003985A
Other languages
English (en)
Portuguese (pt)
Inventor
G Bazan Nicolas
Palacios Pelaez Ricardo
Original Assignee
Univ Louisiana State
Palacios Pelaez Ricardo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Louisiana State, Palacios Pelaez Ricardo filed Critical Univ Louisiana State
Publication of BR112022003985A2 publication Critical patent/BR112022003985A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112022003985A 2019-09-04 2020-09-04 Ácidos graxos poliinsaturados de cadeia muito longa, derivados elovanoides hidroxilados e métodos de uso BR112022003985A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962895737P 2019-09-04 2019-09-04
US201962923770P 2019-10-21 2019-10-21
US201962924359P 2019-10-22 2019-10-22
US202062964995P 2020-01-23 2020-01-23
PCT/US2020/049541 WO2021046448A1 (en) 2019-09-04 2020-09-04 Very-long-chain polyunsaturated fatty acids, elovanoid hydroxylated derivatives, and methods of use

Publications (1)

Publication Number Publication Date
BR112022003985A2 true BR112022003985A2 (pt) 2022-05-24

Family

ID=74853054

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022003985A BR112022003985A2 (pt) 2019-09-04 2020-09-04 Ácidos graxos poliinsaturados de cadeia muito longa, derivados elovanoides hidroxilados e métodos de uso

Country Status (9)

Country Link
US (1) US20220339134A1 (https=)
EP (1) EP4025201A4 (https=)
JP (2) JP2022547080A (https=)
CN (1) CN114650814A (https=)
AU (1) AU2020343029A1 (https=)
BR (1) BR112022003985A2 (https=)
CA (1) CA3153088A1 (https=)
MX (1) MX2022002687A (https=)
WO (1) WO2021046448A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4210689A4 (en) * 2020-09-10 2024-11-13 Board of Supervisors of Louisiana State University and Agricultural and Mechanical College VERY LONG CHAIN POLYUNSATURATED FATTY ACIDS, HYDROXYLATED ELOVANOID DERIVATIVES AND METHODS OF USE THEREOF
CN118524834A (zh) * 2021-12-03 2024-08-20 株式会社日水 氧化应激缓和方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102256990B (zh) * 2008-10-03 2014-09-24 聚糖生物科学有限责任公司 阴离子寡糖轭合物
US20130190399A1 (en) * 2009-10-31 2013-07-25 Martek Biosciences Corporation Synthesis and use of omega-3 and omega 6 very long chain polyunsaturated fatty acids (VLC-PUFA)
JP7025212B2 (ja) * 2015-02-09 2022-02-24 ボード オブ スーパーバイザーズ オブ ルイジアナ ステート ユニバーシティ アンド アグリカルチュアル アンド メカニカル カレッジ 炎症性、変性及び神経変性疾患の治療のための化合物、組成物及び方法
US20170014365A1 (en) * 2015-07-14 2017-01-19 The Board Of Regents Of The University Of Oklahoma Compositions Containing Very Long Chain Saturated Fatty Acids and Methods of Use
WO2017077528A2 (en) * 2015-11-02 2017-05-11 Salzman Lovelace Investments, Ltd. Methods and pharmaceutical compositions for treatment of lung inflammation
CN110730769A (zh) * 2017-03-20 2020-01-24 路易斯安娜州立大学监测委员会，农业和机械学院 极长链多不饱和脂肪酸、类延长素（elovanoid）羟基化衍生物和使用方法
US20220226270A1 (en) * 2019-04-04 2022-07-21 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Very-long-chain polyunsaturated fatty acids, elovanoid hydroxylated derivatives, and methods of use

Also Published As

Publication number Publication date
MX2022002687A (es) 2022-06-16
CA3153088A1 (en) 2021-03-11
EP4025201A1 (en) 2022-07-13
JP2022547080A (ja) 2022-11-10
CN114650814A (zh) 2022-06-21
WO2021046448A1 (en) 2021-03-11
AU2020343029A1 (en) 2022-03-31
JP2025143368A (ja) 2025-10-01
US20220339134A1 (en) 2022-10-27
EP4025201A4 (en) 2023-08-30

Similar Documents

Publication Publication Date Title
BR112021017430A2 (pt) Inibidores da proteína tirosina fosfatase e métodos de uso dos mesmos
BR112021021703A2 (pt) Cicloalquilas substituídas como moduladores da via de estresse integrada
CL2022002521A1 (es) Composiciones y métodos para inhibir la expresión de angptl3
CO2021014835A2 (es) Ácidos grasos poliinsaturados de cadena muy larga, derivados hidroxilados elovanoides y métodos de uso
DOP2024000207A (es) Anticuerpos de cadena pesada multiespecíficos con regiones constantes de cadena pesada modificadas
UY40003A (es) Anticuerpos de cadena pesada multiespecíficos con regiones constantes de cadena pesada modificadas
BR112021021754A2 (pt) Cicloalquilas substituídas como moduladoras da via de estresse integrada
MX2022006700A (es) Compuestos poliheterociclicos como inhibidores de mettl3.
MX2022001874A (es) Receptores agonistas no peptidicos de somatostatina tipo 5 y usos de los mismos.
MX2023002953A (es) Inhibidores de proteína tirosina fosfatasa y métodos para su uso.
CL2021001321A1 (es) Composiciones y métodos para modular la actividad de deshidrogenasas de cadena corta
BR112022010754A2 (pt) Análogos de rapamicina e usos dos mesmos
MX2018014083A (es) Composiciones nutritivas para la proteccion cardiaca en animales de compañia.
BR112018013827A2 (pt) moduladores de 5?-nucleotidase, ecto e uso dos mesmos
BR112022003985A2 (pt) Ácidos graxos poliinsaturados de cadeia muito longa, derivados elovanoides hidroxilados e métodos de uso
BR112023014973A2 (pt) Derivados de urolitina e métodos de uso dos mesmos
CL2023000371A1 (es) Composiciones y métodos para inhibir la expresión de plp1.
MX2022007441A (es) Inhibidores de proteína tirosina fosfatasa y sus métodos de uso.
CY1122591T1 (el) Νεα cυρ-εικοσανοειδη παραγωγα
CO2023004649A2 (es) Un inhibidor de magl
BR112018068414A2 (pt) derivados de ácido a-truxílico e composições farmacêuticas dos mesmos
BR112022010638A2 (pt) Compostos para modular a atividade de fxr e usos dos mesmos
BR112021003983A2 (pt) Pro-fármacos moduladores do receptor de nmda
PE20220486A1 (es) Composiciones solidas que comprenden un derivado de egf(a) y una sal de acido n-(8-(2-hidroxibenzoil)amino)caprilico
BR112021023292A2 (pt) Composto, formulação, composição de vacina, composição farmacêutica, e, método para modular uma resposta imune em um indivíduo

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]